8-12% of the generic market, not the market including the branded drug. That's how I understand it. Maybe I'm wrong, as there are other unknown variables, and possible sales growth of existing products since last quarter...but seeing that we're just contract manufacturing Adderall XR for Prasco I'd expect somewhere around 2-3 million per quarter starting out, that plus current growth gave me my 18.4 million guesstimate. I'd love to be wrong on the short side. We shall see soon enough.
Market Data 
Markets 
AI
